Actinium Pharmaceuticals Inc banner

Intrinsic Value

Is ATNM undervalued or overvalued?

See the intrinsic value estimate for Actinium Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

ATNM Intrinsic Value
LOCKED
Unlock
Today vs. history

ATNM looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with ATNM’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor ATNM
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price $1.02
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to ATNM

Fundamental Analysis

What Actinium Pharmaceuticals Does

Biotechnology Health Care

Actinium Pharmaceuticals is a biotechnology company focused on targeted radiation drugs for cancer. Its core idea is to attach a radioactive payload to an antibody so the treatment can seek out specific cancer cells or the cells that make blood and immune systems. The company’s lead work has centered on therapies for hard-to-treat blood cancers, where precise delivery matters because standard chemotherapy can be too blunt.

Headquarters
United States of America US
Employees
49
IPO date
Mar 26, 2014
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Actinium Pharmaceuticals Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

ATNM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ATNM stock?

The intrinsic value for Actinium Pharmaceuticals Inc (ATNM) under the Base Case is hidden USD.

Is ATNM stock undervalued or overvalued?

Compared with the current market price of 1.0172 USD, the stock appears hidden.

Back to Top